BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25443702)

  • 1. Dehydroepiandrosterone and its sulfate predict the 5-year risk of coronary heart disease events in elderly men.
    Tivesten Å; Vandenput L; Carlzon D; Nilsson M; Karlsson MK; Ljunggren Ö; Barrett-Connor E; Mellström D; Ohlsson C
    J Am Coll Cardiol; 2014 Oct; 64(17):1801-10. PubMed ID: 25443702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum levels of dehydroepiandrosterone sulfate predict all-cause and cardiovascular mortality in elderly Swedish men.
    Ohlsson C; Labrie F; Barrett-Connor E; Karlsson MK; Ljunggren O; Vandenput L; Mellström D; Tivesten A
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4406-14. PubMed ID: 20610590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum DHEA and Its Sulfate Are Associated With Incident Fall Risk in Older Men: The MrOS Sweden Study.
    Ohlsson C; Nethander M; Karlsson MK; Rosengren BE; Ribom E; Mellström D; Vandenput L
    J Bone Miner Res; 2018 Jul; 33(7):1227-1232. PubMed ID: 29528519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden.
    Ohlsson C; Barrett-Connor E; Bhasin S; Orwoll E; Labrie F; Karlsson MK; Ljunggren O; Vandenput L; Mellström D; Tivesten A
    J Am Coll Cardiol; 2011 Oct; 58(16):1674-81. PubMed ID: 21982312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Are Associated With Coronary Heart Disease in Men With Type 2 Diabetes Mellitus.
    Zhang X; Xiao J; Liu T; He Q; Cui J; Tang S; Li X; Liu M
    Front Endocrinol (Lausanne); 2022; 13():890029. PubMed ID: 35832423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women.
    Jia X; Sun C; Tang O; Gorlov I; Nambi V; Virani SS; Villareal DT; Taffet GE; Yu B; Bressler J; Boerwinkle E; Windham BG; de Lemos JA; Matsushita K; Selvin E; Michos ED; Hoogeveen RC; Ballantyne CM
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4304-27. PubMed ID: 32785663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relationship between androgens concentrations (testosterone and dehydroepiandrosterone sulfate) and metabolic syndrome in non-obese elderly men].
    Rabijewski M; Papierska L; Kozakowski J; Zgliczyński W
    Endokrynol Pol; 2007; 58(6):496-504. PubMed ID: 18205106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2007; 58(3):213-9. PubMed ID: 17940987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous sex hormones and cardiovascular disease incidence in men.
    Arnlöv J; Pencina MJ; Amin S; Nam BH; Benjamin EJ; Murabito JM; Wang TJ; Knapp PE; D'Agostino RB; Bhasin S; Vasan RS
    Ann Intern Med; 2006 Aug; 145(3):176-84. PubMed ID: 16880459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
    Arlt W; Haas J; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of DHEA-S and estradiol serum levels to symptoms of aging men.
    Ponholzer A; Plas E; Schatzl G; Jungwirth A; Madersbacher S;
    Aging Male; 2002 Dec; 5(4):233-8. PubMed ID: 12630070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.
    Barrett-Connor E; Khaw KT; Yen SS
    N Engl J Med; 1986 Dec; 315(24):1519-24. PubMed ID: 2946952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do DHEA/DHEAS play a protective role in coronary heart disease?
    Porsová-Dutoit I; Sulcová J; Stárka L
    Physiol Res; 2000; 49 Suppl 1():S43-56. PubMed ID: 10984071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum dehydroepiandrosterone sulphate level correlates with increased risk for metabolic syndrome in the elderly men.
    Chen YC; Chang HH; Wen CJ; Lin WY; Chen CY; Hong BS; Huang KC
    Eur J Clin Invest; 2010 Mar; 40(3):220-5. PubMed ID: 20050878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum DHEA and Testosterone Levels Associate Inversely With Coronary Artery Calcification in Elderly Men.
    Ohlsson C; Nethander M; Norlén AK; Poutanen M; Gudmundsson EF; Aspelund T; Sigurdsson S; Ryberg H; Gudnason V; Tivesten Å
    J Clin Endocrinol Metab; 2023 Nov; 108(12):3272-3279. PubMed ID: 37391895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DHEA and mortality: what is the nature of the association?
    Ohlsson C; Vandenput L; Tivesten A
    J Steroid Biochem Mol Biol; 2015 Jan; 145():248-53. PubMed ID: 24704256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum adrenal androgen dehydroepiandrosterone sulfate and mortality in hemodialysis patients.
    Kakiya R; Shoji T; Hayashi T; Tatsumi-Shimomura N; Tsujimoto Y; Tabata T; Shima H; Mori K; Fukumoto S; Tahara H; Koyama H; Emoto M; Ishimura E; Nishizawa Y; Inaba M
    Nephrol Dial Transplant; 2012 Oct; 27(10):3915-22. PubMed ID: 22764194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.
    Martina V; Benso A; Gigliardi VR; Masha A; Origlia C; Granata R; Ghigo E
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):260-4. PubMed ID: 16487434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.
    Frystyk J; Berne C; Berglund L; Jensevik K; Flyvbjerg A; Zethelius B
    J Clin Endocrinol Metab; 2007 Feb; 92(2):571-6. PubMed ID: 17119002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.